Saby George - Dissemin

Dissemin is shutting down on January 1st, 2025

Language
Login

All papers authored by Saby George

This paper was not found in any repository, but could be made available legally by the author.

2023 Daniel P. Petrylak

ORCID

, Bernhard J. Eigl

ORCID

, Saby George

ORCID

, Elisabeth I. Heath

ORCID

, Sebastien J. Hotte

ORCID

, David D. Chism

ORCID

, Lisle M. Nabell

ORCID

ORCID

, Susanna Y. Cheng

ORCID

, Leonard J. Appleman

ORCID

, Guru P. Sonpavde

ORCID

, Alicia K. Morgans

ORCID

, Pourya Pourhosseini

ORCID

ORCID

, Laura Standley

ORCID

and 2 other authors

Phase I Dose-Escalation Study of the Safety and Pharmacokinetics of AGS15E Monotherapy in Patients with Metastatic Urothelial Carcinoma

Upload

This paper was not found in any repository, but could be made available legally by the author.

2020 Nizar M. Tannir, Sabina Signoretti

ORCID

, Toni K. Choueiri, David F. McDermott, Robert J. Motzer

ORCID

, Abdallah Flaifel

ORCID

, Jean-Christophe Pignon, Miriam Ficial

ORCID

, Osvaldo Arén Frontera, Osvaldo Arén Frontera, Saby George

ORCID

, Thomas Powles, Frede Donskov

ORCID

, Michael R. Harrison, Philippe Barthélémy and 10 other authors

Efficacy and Safety of Nivolumab Plus Ipilimumab versus Sunitinib in First-Line Treatment of Patients with Advanced Sarcomatoid Renal Cell Carcinoma

Upload

This paper was not found in any repository, but could be made available legally by the author.

Jean-Francois Martini

ORCID

, Elizabeth R. Plimack, Toni K. Choueiri, David F. McDermott, Igor Puzanov, Mayer N. Fishman, Daniel C. Cho, Ulka Vaishampayan, Brad Rosbrook, Kathrine C. Fernandez, Jamal C. Tarazi

ORCID

, Saby George

ORCID

, Michael B. Atkins

Angiogenic and immune-related biomarkers and outcomes following axitinib/pembrolizumab treatment in patients with advanced renal cell carcinoma

Upload

This paper is made freely available by the publisher.

Bradley A. McGregor

ORCID

, Michael Gordon

ORCID

, Ronan Flippot

ORCID

, Neeraj Agarwal

ORCID

, Saby George

ORCID

, David I. Quinn

ORCID

, Mark Rogalski, Thomas Hawthorne, Tibor Keler

ORCID

, Toni K. Choueiri

ORCID

Safety and efficacy of CDX-014, an antibody-drug conjugate directed against T cell immunoglobulin mucin-1 in advanced renal cell carcinoma

Download from link.springer.com

This paper is made freely available by the publisher.

Yuanquan Yang

ORCID

, Rohit K. Jain, Sean T. Glenn, Bo Xu, Prashant K. Singh, Lei Wei, Qiang Hu, Mark Long, Nicholas Hutson, Jianming Wang, Sebastiano Battaglia, Saby George

ORCID

Complete response to anti-PD-L1 antibody in a metastatic bladder cancer associated with novel MSH4 mutation and microsatellite instability

Download from doi.org

This paper is made freely available by the publisher.

2019 Lawrence Fong, Andrew Hotson, John D. Powderly, Mario Sznol, Rebecca S. Heist, Toni K. Choueiri, Saby George

ORCID

, Brett G. M. Hughes, Matthew D. Hellmann

ORCID

, Dale R. Shepard, Brian I. Rini, Shivaani Kummar, Amy M. Weise, Matthew J. Riese, Ben Markman and 18 other authors

Adenosine 2A Receptor Blockade as an Immunotherapy for Treatment-Refractory Renal Cell Cancer

Download from aacrjournals.org

This paper is made freely available by the publisher.

Anthony Wood, Saby George

ORCID

, Nabil Adra, Sreenivasulu Chintala, Nur Damayanti, Roberto Pili

ORCID

Phase I study of the mTOR inhibitor everolimus in combination with the histone deacetylase inhibitor panobinostat in patients with advanced clear cell renal cell carcinoma

Download from link.springer.com

This paper was not found in any repository, but could be made available legally by the author.

Taha Bat, Dennis A. Buck, Rachel Nathan, Jordan Cinquino, Marcus Sikorski

ORCID

, Angie Elefante, Laurie Herbst, Norbert Sule, Andrew Fabiano, Saby George

ORCID

Advanced Bladder Cancer Rechallenged With an Immune Checkpoint Inhibitor: A Case Report

Upload

This paper was not found in any repository, but could be made available legally by the author.

Robert J. Motzer, Brian I. Rini, David F. McDermott, Osvaldo Arén Frontera, Osvaldo Aren Frontera, Hans J. Hammers, Michael A. Carducci, Pamela Salman, Bernard Escudier, Benoit Beuselinck, Asim Amin, Camillo Porta, Saby George

ORCID

, Victoria Neiman, Sergio Bracarda and 27 other authors

Nivolumab plus ipilimumab versus sunitinib in first-line treatment for advanced renal cell carcinoma: extended follow-up of efficacy and safety results from a randomised, controlled, phase 3 trial

Upload

This paper was not found in any repository, but could be made available legally by the author.

Ethan M. Basch, Mark Scholz, Johann S. de Bono, Nicholas Vogelzang, Paul de Souza, Gavin Marx, Ulka Vaishampayan, Saby George

ORCID

, James K. Schwarz, Emmanuel S. Antonarakis, Joseph M. O'Sullivan, Arash Rezazadeh Kalebasty, Kim N. Chi, Robert Dreicer, Thomas E. Hutson and 7 other authors

Cabozantinib Versus Mitoxantrone-prednisone in Symptomatic Metastatic Castration-resistant Prostate Cancer: A Randomized Phase 3 Trial with a Primary Pain Endpoint

Upload

This paper was not found in any repository, but could be made available legally by the author.

Ahmad Hanif, Manu Pandey, Sumera Khan, Kristopher Attwood, Saby George

ORCID

Metastatic sarcomatoid renal cell carcinoma treated with immune checkpoint inhibitors

Upload

This paper was not found in any repository, but could be made available legally by the author.

Nieves Martínez Chanzá, Wanling Xie, Mehmet Asim Bilen, Hannah Dzimitrowicz, Jarred Burkart, Daniel M. Geynisman, Archana Balakrishnan, I. Alex Bowman, Rohit Jain, Walter Stadler, Yousef Zakharia, Vivek Narayan, Benoit Beuselinck, Rana R. McKay, Abhishek Tripathi and 23 other authors

Cabozantinib in advanced non-clear-cell renal cell carcinoma: a multicentre, retrospective, cohort study

Upload

Distributing this paper is prohibited by the publisher

Saby George

ORCID

, Brian I. Rini, Hans J. Hammers

Emerging Role of Combination Immunotherapy in the First-line Treatment of Advanced Renal Cell Carcinoma

Upload

This paper was not found in any repository, but could be made available legally by the author.

David Cella, Viktor Gruenwald, Viktor Grünwald, Bernard Escudier, Hans J. Hammers, Saby George

ORCID

ORCID

, Marc-Oliver Grimm, Brian I. Rini, Justin Doan, Cristina Ivanescu, Jean Paty, Sabeen Mekan, Robert J. Motzer

Patient-reported outcomes of patients with advanced renal cell carcinoma treated with nivolumab plus ipilimumab versus sunitinib (CheckMate 214): a randomised, phase 3 trial

Upload

This paper was not found in any repository; the policy of its publisher is unknown or unclear.

R. J. Motzer, E. Jonasch, M. Dror Michaelson, L. Nandagopal, J. L. Gore, S. George

ORCID

, A. Alva, N. Haas, M. R. Harrison, E. R. Plimack, J. Sosman, N. Agarwal, S. Bhayani, T. K. Choueiri, Costello and 20 other authors

Featured updates to the NCCN guidelines

Upload

This paper is made freely available by the publisher.

2018 A. Boilève, M. I. Carlo

ORCID

, P. Barthélémy, S. Oudard

ORCID

, D. Borchiellini, M. H. Voss, S. George

ORCID

, C. Chevreau, J. Landman-Parker, M.-D. Tabone, D. D. Chism, A. Amin, M. A. Bilen, D. Bosse, A. Coulomb-L’hermine and 4 other authors

Immune checkpoint inhibitors in MITF family translocation renal cell carcinomas and genetic correlates of exceptional responders

Download from link.springer.com

This paper was not found in any repository, but could be made available legally by the author.

B. I. Rini, N. M. Tannir, B. Escudier, D. F. McDermott, M.-O. Grimm, C. Porta, T. Powles, C. K. Kollmannsberger, H. P. Gurney, S. S. Tykodi, M. Harrison, D. Y. C. Heng, V. Grünwald, T. K. Choueiri, S. Mekan and 4 other authors

Characterization of response to nivolumab plus ipilimumab (N+I) or sunitinib (S) in patients (Pts) with previously untreated advanced renal cell carcinoma (arcc): Checkmate 214

Upload

This paper was not found in any repository, but could be made available legally by the author.

D. F. McDermott, B. I. Rini, R. J. Motzer, N. M. Tannir, B. Escudier, C. K. Kollmannsberger, H. J. Hammers, C. Porta, S. George

ORCID

, F. Donskov, H. P. Gurney, M.-O. Grimm, M. Harrison, T. E. Hutson, J. Doan and 5 other authors

Treatment-free interval (TFI) following discontinuation of first-line nivolumab plus ipilimumab (N+I) or sunitinib (S) in patients (Pts) with advanced renal cell carcinoma (aRCC): CheckMate 214 analysis

Upload

This paper is made freely available by the publisher.

Paul Monk

ORCID

, Glenn Liu, Walter M. Stadler, Susan Geyer, Ying Huang, John Wright, Miguel Villalona-Calero, James Wade, Russell Szmulewitz, Shilpa Gupta, Amir Mortazavi, Robert Dreicer, Roberto Pili, Nancy Dawson, Saby George

ORCID

and 1 other authors

Phase II randomized, double-blind, placebo-controlled study of tivantinib in men with asymptomatic or minimally symptomatic metastatic castration-resistant prostate cancer (mCRPC)

Download from link.springer.com

This paper was not found in any repository, but could be made available legally by the author.

Saby George

ORCID

, Antonios Papanicolau-Sengos, Felicia L. Lenzo, Jeffrey M. Conroy, Mary Nesline, Sarabjot Pabla, Sean T. Glenn, Blake Burgher, Jonathan Andreas, Vincent Giamo, Moachun Qin, Yirong Wang, Lorenzo Galluzzi, Carl Morrison

PD-L2 amplification and durable disease stabilization in patient with urothelial carcinoma receiving pembrolizumab

Upload

Missing publications? Search for publications with a matching author name.